tirzepatide through lilly FDA says the weight-loss drug shortage is over Eli Lilly just issued a

Plasma FABP1 levels are significantly elevated in AD patients and are positively correlated with cerebrospinal fluid (CSF) total tau and phosphorylated tau

Weight-loss drugs such as Wegovy (marketed for the treatment of diabetes under the name Ozempic) have become Hollywoods biggest slimming secret and soon there may be an even more potent pound buster on the market

No specific reports state Amgen is using Omniverse, but given Amgens size, it may also leverage digital tools (Amgen has partnership with NVIDIA in the past for GPU-accelerated drug discovery)

Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed mean body weight reductions of approximately 24% at 48 weeks with the highest dose, with no clear plateau observed